ANI Pharmaceuticals, Inc. (ANIP), Wednesday announced the launch of Nitazoxanide Tablets, 500 mg that are the generic version of the reference listed drug Alinia.
Nikhil Lalwani, President and Chief Executive Officer of the company stated that the launch of Nitazoxanide Tablets aligns with their purpose of 'Serving Patients, Improving Lives'.
Notably, based on December 2024 moving annual total IQVIA data, total U.S. annual sales for Nitazoxanide Tablets stood at approximately $36.1 million.
In the pre-market hours, ANI's stock is trading at $63.22, down 1.56 percent on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.